173 related articles for article (PubMed ID: 23107584)
1. Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome.
Gao C; Devarajan K; Zhou Y; Slater CM; Daly MB; Chen X
BMC Genomics; 2012 Oct; 13():570. PubMed ID: 23107584
[TBL] [Abstract][Full Text] [Related]
2. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity.
Tchatchou S; Riedel A; Lyer S; Schmutzhard J; Strobel-Freidekind O; Gronert-Sum S; Mietag C; D'Amato M; Schlehe B; Hemminki K; Sutter C; Ditsch N; Blackburn A; Hill LZ; Jerry DJ; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Wappenschmidt B; Schmutzler RK; Engel C; Meindl A; Bartram CR; Mollenhauer J; Burwinkel B
Hum Mutat; 2010 Jan; 31(1):60-6. PubMed ID: 19830809
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
4. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.
Blackburn AC; Hill LZ; Roberts AL; Wang J; Aud D; Jung J; Nikolcheva T; Allard J; Peltz G; Otis CN; Cao QJ; Ricketts RS; Naber SP; Mollenhauer J; Poustka A; Malamud D; Jerry DJ
Am J Pathol; 2007 Jun; 170(6):2030-41. PubMed ID: 17525270
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
6. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.
Choudhury S; Almendro V; Merino VF; Wu Z; Maruyama R; Su Y; Martins FC; Fackler MJ; Bessarabova M; Kowalczyk A; Conway T; Beresford-Smith B; Macintyre G; Cheng YK; Lopez-Bujanda Z; Kaspi A; Hu R; Robens J; Nikolskaya T; Haakensen VD; Schnitt SJ; Argani P; Ethington G; Panos L; Grant M; Clark J; Herlihy W; Lin SJ; Chew G; Thompson EW; Greene-Colozzi A; Richardson AL; Rosson GD; Pike M; Garber JE; Nikolsky Y; Blum JL; Au A; Hwang ES; Tamimi RM; Michor F; Haviv I; Liu XS; Sukumar S; Polyak K
Cell Stem Cell; 2013 Jul; 13(1):117-30. PubMed ID: 23770079
[TBL] [Abstract][Full Text] [Related]
10. The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.
Johnson JK; Waddell N; ; Chenevix-Trench G
BMC Cancer; 2012 Jun; 12():246. PubMed ID: 22703186
[TBL] [Abstract][Full Text] [Related]
11. Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.
Alvarez C; Aravena A; Tapia T; Rozenblum E; Solís L; Corvalán A; Camus M; Alvarez M; Munroe D; Maass A; Carvallo P
BMC Cancer; 2016 Mar; 16():219. PubMed ID: 26979459
[TBL] [Abstract][Full Text] [Related]
12. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
Staff S; Nupponen NN; Borg A; Isola JJ; Tanner MM
Genes Chromosomes Cancer; 2000 Aug; 28(4):432-42. PubMed ID: 10862052
[TBL] [Abstract][Full Text] [Related]
13. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.
Li Y; Pan J; Li JL; Lee JH; Tunkey C; Saraf K; Garbe JC; Whitley MZ; Jelinsky SA; Stampfer MR; Haney SA
Mol Cancer; 2007 Jan; 6():7. PubMed ID: 17233903
[TBL] [Abstract][Full Text] [Related]
15. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
18. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
19. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
[TBL] [Abstract][Full Text] [Related]
20. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]